Job Recruitment Website - Zhaopincom - How about Jiangsu Bikang Xinyang Pharmaceutical Co., Ltd.?

How about Jiangsu Bikang Xinyang Pharmaceutical Co., Ltd.?

Jiangsu Bikang Xinyang Pharmaceutical Co., Ltd. is a limited liability company (wholly owned by a legal person invested or controlled by a natural person) registered in xinyi city, Xuzhou City, Jiangsu Province on February 1, 214, with its registered address at No.168-1 Malingshan West Road, xinyi city Economic Development Zone.

The unified social credit code/registration number of Jiangsu Bikang Xinyang Pharmaceutical Co., Ltd. is 913238191515631K, and the enterprise legal person is Wang Cheng. At present, the enterprise is in the state of opening.

The business scope of Jiangsu Bikang Xinyang Pharmaceutical Co., Ltd. is: pharmaceutical technology research and development and technology transfer; Sales of daily necessities, health food, cosmetics, sanitary products and disinfection and sterilization products; Chinese herbal medicine cultivation; Purchase of agricultural products (excluding tobacco leaves, grain and silkworm cocoons); Wholesale of Chinese patent medicines, Chinese herbal medicines, Chinese herbal pieces, chemical preparations, chemical raw materials, antibiotics, biochemical drugs and biological products; Wholesale and retail of health food; Sales of Class II medical devices (except diagnostic reagents); Sales of Class III medical devices (except diagnostic reagents); Protein assimilation preparation, peptide hormone sales. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is 696.24 million yuan, and the main capital is concentrated in 1-5 million and 1-1 million enterprises, with 15 companies. Within the province, the registered capital of current enterprises is excellent.

view more information and information of Jiangsu bikang Xinyang pharmaceutical co., ltd through Baidu enterprise credit.